Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xinjun Liang
Institutions:
Hubei Cancer Hospital,
Huazhong University of Science and Technology
Observed institutions:
Hubei Cancer Hospital,
Huazhong University of Science and Technology
ORCID:
0000-0002-5180-7926
Observed ORCID:
0000-0002-5180-7926
OpenAlex ID:
A5123382344
From Thresholds to Tumor Sidedness: Reframing Human Epidermal Growth Factor Receptor 2 in Colorectal Cancer
2026
·
Xinjun Liang
, Hao Lei
·
Journal of Clinical Oncology
·
1
A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study)
2026
·
Do-Youn Oh
, Winnie Yeo
, et al.
·
Cancer Research and Treatment
PDF
A phase I, first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activities of GenSci139 in patients with solid tumors.
2026
·
Jinming Yu
, Yuping Sun
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
3
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type